John C. Breneman, M.D.

EDUCATION:

HOSPITAL TRAINING:

LICENSURE:

BOARD CERTIFICATION:

HONORS AND AWARDS:

ACADEMIC APPOINTMENTS:

PROFESSIONAL APPOINTMENTS:

PROFESSIONAL SOCIETIES:

TEACHING:

NATIONAL:

LOCAL:

• Daily one-on-one instruction of residents and medical students in the inpatient and outpatient setting
• Participant weekly Radiation Oncology Grand Rounds
• Participant monthly Mycosis Fungoides Journal Club
• Radiation Therapy Technology Program - Simulation Laboratory (weekly 1985-1992)
• Speaker at Mycosis Fungoides Support Group
• Clinical Opportunities Program preceptor for first-year medical students (1987-88)
• Physical Diagnosis Instructor for second-year medical students (1987-88)
• Summer Oncology Lecture Series speaker (1985-88)
• Contributor to Radiation Oncology "Chart Rounds" newsletter, Mycosis
• Fungoides Network, and Barrett Cancer Center Newsletter
• Faculty Advisor for Medical Students (1997-2000)

COMMITTEES (University):

COMMITTEES (National):

CLINICAL RESEARCH (Children's Cancer Study Group [CCSG] and ChildrenÕs Oncology Group [COG]):

ADMINISTRATIVE AND STRATEGY COMMITTEES:

SCIENTIFIC COMMITTEES:

DISEASE SITE STUDY COMMITTEES (Designing, writing, administering clinical studies):

CLINICAL RESEARCH (Intergroup Rhabdomyosarcoma Study Group [IRSG]) PARTICIPATION:

CLINICAL RESEARCH (University of Cincinnati):

• Co-investigator, "Herpes virus TK mediated gene therapy of high grade glial tumors."
• Principal Investigator, " A double blind randomized placebo-controlled bilateral study to evaluate the safety and efficacy of vitamin E cream for the prevention of radiation dermatitis."
• Co-investigator, "Sensitive detection of monoclonal T lymphocytes in patients with mycosis fungoides/ Sezary syndrome."
• Principal Investigator, "Multi-modality therapy of intermediate and poor prognosis mycosis fungoides."
• Principal Investigator, "Deoxycoformycin and Interferon Alpha-2a for treatment of advanced or refractory mycosis fungoides with or without the Sezary syndrome," in conjunction with the National Cancer Institute.
• Principal Investigator, "Treatment of mycosis fungoides limited to the skin and lymph nodes," in conjunction with the National Cancer Institute.
• Principal Investigator, "A phase I/II study of simultaneous intra-arterial cisplatin and stereotactic radiosurgery for the treatment of recurrent gliomas."
• Principal Investigator, "A prospective, non-randomized trial of synchronous external irradiation plus cis- diamminedichloroplatinum (CDDP) and 5-fluorouracil (5-FU) for treatment of unresectable, non- metastatic squamous cell carcinoma of the lung."
• Co-Investigator, "A study to determine the uniformity of cutaneous distribution and potential for environmental contamination with topical mechlorethamine using aqueous and ointment vehicles commonly used in the preparation of topical mechlorethamine for the treatment of mycosis fungoides."
• Co-Investigator, "Phase 1-2 evaluation of topical LDG1069 in patients with cutaneous T-cell lymphoma (mycosis fungoides.)"
• Principal Investigator, "Phase I/II Dose Escalation Trial of 3-D Radiotherapy in the Treatment of Recurrent Glioblastoma."
• Co-Investigator, "Prospective, Open Label, Parallel-Group, Randomized, Multicenter Trial Comparing the Efficacy of Surgery, Radiation, and Injection of Murine Cells Producing Herpes Simplex Thymidine Kinase Vector Followed by Intravenous Ganciclovir Against the Efficacy of Surgery and Radiation in the Treatment of Newly Diagnosed, Previously Untreated Glioblastoma."
• Principal Investigator, "Evaluation of multi-modality image fusion software for use in stereotactic radiosurgery."
• Principal Investigator, "Evaluation of X-knife 4 treatment planning software in stereotactic radiosurgery."
• Co-investigator, "Protocol for the treament of advanced or refractory mycosis fungoides with or without the sezary syndrome."
• Co-investigator, "Study to determine the laboratory methods most effective in diagnosing blood involvement in patients with mycosis fungoides or the sezary syndrome."
• Co-investigator, "Treatment of patients with intermediate and advanced mycosis fungoides/Sezary syndrome with zidovudine (AZT) and interferon alpha."
• Co-investigator, "Phase II-III evaluation of Targretin Capsules in patients with refractory or persistent early stage cutaneous T-cell lymphoma."
• Co-investigator, "Phase II-III evaluation of Targretin Capsules in patients with refractory advanced stage cutaneous T-cell lymphoma."
• Co-investigator, "Phase III evaluation of Targretin Topical Gel in patients with refractory or persistent early stage cutaneous T- cell llymphoma."
• Principal Investigator, "Phase I/II trial of permanant I-125 implants in the treament of newly diagnosed glioblastoma multiforme."
• Co-investigator, "A phase I study of concurrent multi-modality treatment for patients with relapsed malignant glioma using permanent I-125 interstitial seeds and dose escalation of gliadel 3.85% carmustine (BCNU) polymer wafers."
• Co-investigator, "A phase I/II study of a recombinant chimeric protein composed of circularly permuted IL-4 and a mutated form of the Pseudomonas exotoxin termed IL-4(38-37)-PE38KDEL (IL-4 toxin) for the treatment of recurrent malignant astrocytoma."
• Co-investigator, "A phase I/II trial of hyperbaric oxygen and 3D conformal radiotherapy for the treatment of newly diagnosed glioblastoma multiforme." ($25,000 funding from The Neuroscience Institute)

CLINICAL ACCOMPLISHMENTS:

• Implemented High Precision Radiotherapy Center at the Barrett Cancer Center.
• Implemented 3-D conformal treatment planning at the Barrett Cancer Center.
• Developed three-dimensional stereotactic treatment planning system for implantation of brain tumors.
• Co-established the stereotactic radiosurgery program at the Barrett Cancer Center.
• Co-established the multidisciplinary neuro-oncology group at Children's Hospital Medical Center.
• Co-established the multidisciplinary neuro-oncology group at Barrett Cancer Center
• Co-established the multidisciplinary mycosis fungoides group at the University of Cincinnati.
• Established the adult total body irradiation program at the University of Cincinnati for use in bone marrow transplantation program.
• Developed capabilities for three-dimensional tissue compensation during radiotherapy at the University of Cincinnati.
• Member of Children's Hospital Medical Center Bone Marrow Transplant Decision Team.
• Member of the Skull Base Surgery Team at the University of Cincinnati.

NATIONAL & INTERNATIONAL PRESENTATIONS:

1. McLaurin R, Breneman J, Aron B: Hypothalamic Gliomas. XIV Congress of the International Society for Pediatric Neurosurgery. Madrid, Spain, 10/3/86.
2. Breneman J, Bradshaw AE, et al: Adjuvant radiation therapy for prevention of tracheostomy recurrences in patients requiring emergency tracheostomy for head and neck cancer. Second International Head and Neck Oncology Research Conference. Arlington, VA, 9/9-11/87.
3. Van Aken ML, Breneman JC, et al: Incorporation of patient immobilization, tissue compensation and matchline junction technique for three-field breast treatment. 13th Annual Meeting of the American Association of Medical Dosimetrists. Toronto, Canada, 6/26-7/1/88.
4. Breneman JC, Elson HR, et al: A technique for delivery of total body irradiation for bone marrow transplantation in adults and adolescents. American Society for Therapeutic Radiology and Oncology annual meeting. New Orleans, LA, 10/10-14/88. (Poster)
5. Breneman JC: Electron beam therapy. Dermatologic Radiotherapy Society. San Francisco, CA, 12/5/89.
6. Steele P, Breneman DL, Breneman JC, et al: Genotypic analysis of lymph nodes in cutaneous T cell lymphomas: Comparison with histologic "LN" grading. United States and Canadian Academy of Pathology Annual Meeting, 3/90.
7. Foss F, Fischmann A, Schechter G, Ihde D, Breneman D, Breneman J, et al: Phase II trial of human Interferon-Alfa-2A and Pentostatin in advanced stage mycosis fungoides/Sezary syndrome. American Society for Clinical Oncology annual meeting. Washington, D.C., 5/20-22/90. (Poster)
8. Heerema N, Arthur D, Steinherz P, Gaynon P, Sather H, Breneman J, et al: Children with acute lymphoblastic leukemia with lymphomatous features (ALL-LF) and normal marrow chromosomes have a better outcome than patients with abnormal chromosomes. American Society for Clinical Oncology annual meeting. Washington, D.C., 5/20-22/90.
9. Cherlow J, Steinherz P, Sather H, Gaynon P. Grossman N, Kersey J, Maurer H, Breneman J, et al: The role of radiation therapy in the management of acute lymphoblastic leukemia with lymphomatous presentation (ALL/LP). American Society for Therapeutic Radiology and Oncology. Miami, FL, 10/90.
10. Gerson J, Breneman J: Stereotactic radiosurgery: The initial experience at the University of Cincinnati. 51st Annual Meeting of the Ohio State Radiological Society, Columbus, OH, 5/2-5/91.
11. Maheshwari A, Breneman J, Burke M, Aron B: University of Cincinnati 20-year experience with retinoblastomas. 51st Annual Meeting of the Ohio State Radiological Society, Columbus, OH 5/2-5/91.
12. Breneman JC: Electron beam therapy of cutaneous lymphomas and cutaneous carcinomas. American Academy of Dermatology Annual Meeting, Dallas, TX, 12/9/91.
13. Steinherz P, Gaynon P, Breneman J, Cherlow J, et al: Treatment of acute lymphoblastic leukemia with lymphatous presenting features. Medical Pediatric Oncology Society Annual Meeting, Rhodes, Greece, 1991.
14. Sorensen SM, Barron DR, Breneman DL, Breneman JC: Paraffin section immunohistologic evaluation of cutaneous T cell lymphomas (CTCL): The role of OPD4. United States and Canadian Academy of Pathology, Atlanta, GA, 3/14-20/92 (poster).
15. Breneman DL, Swerdlow SH, Jacobs DR, Cline DJ, Barron DR, Ballman EA, Steele PE, Breneman J: Concurrent lymphomatoid papulosis and mycosis fungoides. 18th World Congress of Dermatology, New York, NY, 6/12-18/92.
16. Shehata WM, Ploysongsang S, Breneman JC, Gerson JW, Tew JW: Interstitial brain brachytherapy. American Radium Society, Orlando, FL, 4/26-29/92.
17. Steinherz P, Gaynon P, Breneman JC, et al: Acute lymphoblastic leukemia (ALL) with lymphomatous features at diagnosis in children. ASCO Annual Meeting, San Diego, CA, 5/17-19/92.
18. Breneman DL, Like-Nartker A, Ballman EA, Pruemer JM, Blumsack RF, David M, Breneman JC: Topical mechlorethamine in the treatment of mycosis fungoides - Uniformity of application and potential for environmental contamination. 18th World Congress of Dermatology. New York City, NY, 6/12-18/92.
19. Breneman DL, Breneman JC, et al: Hair and nail changes following total skin irradiation. 18th World Congress of Dermatology. New York City, NY, 6/12-18/92.
20. Breneman DL, Breneman JC, et al: Sezary syndrome: Long-term remission following topical corticosteroid therapy. 18th World Congress of Dermatology. New York, NY, 6/12-18/92.
21. Breneman DL, Swerdlow SH, Jacobs BS, Cline DJ, Baron DR, Ballman EA, Steele PE, Breneman JC: Concurrent Ki-1 lymphoma, lymphomatoid papulosis and mycosis fungoides. 18th World Congress of Dermatology. New York, NY, 6/12-18/92.
22. Malik S, Mazewski C, Lucky A, Breneman J, et al: Ultraviolet-B and total skin electron beam therapy for refractory cutaneous lesions of Langerhans cell histiocytosis: A case report. American Society of Pediatric Hematology/Oncology, Chicago, IL, 9/24-26/92.
23. Breneman DL, Breneman JC, Wachendorf TJ, Rindler JM, Ballman EA: Hair and nail changes following total skin irradiation. 18th World Cong Dermatol, New York, NY, 6/15/92.
24. Breneman DL, Swerdlow SH, Breneman JC, Ballman EA, Kuhlman DS, Steele PE: Concurrent Ki-1 lymphoma, lymphomatoid papulosis, and mycosis fungoides. 18th World Cong Dermatol, New York, NY, 6/15/92 (exhibit).
25. Breneman DL, Swerdlow SH, Jacobs BS, Cline DJ, Barron DR, Ballman EA, Steele PE, Breneman JC: Concurrent lymphomatoid papulosis and mycosis fungoides. 18th World Cong of Dermatol, New York, NY, 6/16/92.
26. Breneman DL, Breneman JC, Swerdlow SH, Ballman EA, Steele PE, Foss FM: Sezary syndrome: Long-term remission following topical corticosteroid therapy. 18th World Cong Dermatol, New York, NY, 6/16/92.
27. Breneman DL, Like-Nartker A, Ballman EA, Pruemer JM, Bluksack RF, Davis M, Breneman JC: Topical mechlorethamine in the treatment of mycosis fungoides - uniformity of application and potential for environmental contamination. 18th World Cong Dermatol, New York, NY, 6/16/92 (exhibit).
28. Breneman J, Lamba M, et al: Treatment planning of stereotactic brain implants using an interactive graphical system. American Society for Therapeutic Radiology and Oncology Annual Meeting, San Diego, CA, 11/7-12/92.
29. Breneman J, Lamba M, et al: Treatment planning of stereotactic brain implants using an interactive graphical system. Radiologic Society of North America, Chicago, IL, 12/2-6/92.
30. Warnick RE, Lamba MA, Elson HR, Breneman JC, Tew JM: A novel refixation device for fractionated stereotactic radiosurgery. American Association of Neurological Surgeons Annual Meeting, Boston, MA, 4/24-29/93.
31. Sheth PB, Breneman DL, Swerdlow SH, Croen K, Mutasim D, Steele PE, Whittington C, Ballman E, Breneman J: Granuloma formation in two patients with adult T-cell leukemia/lymphoma in sites of previous herpes zoster. American Academy of Dermatology Annual Meeting. Washington, DC 12/5/93.
32. Breneman DL, Cline DJ, Swerdlow SH, Steele PE, Breneman JC: Concurrent lymphomatoid papulosis and mycosis fungoides. American Academy of Dermatology Annual Meeting. Washington, DC 12/5/93.
33. Breneman DL, Breneman JC, et al: Primary cutaneous CD-30 positive large cell lymphoma. American Academy of Dermatology Annual Meeting, Washington, D.C., 12/5/93.
34. Breneman JC: Electron Beam Therapy. American Academy of Dermatology Annual Meeting, Washington, DC, 12/5/93.
35. hildress L, Litz G, Cualing H, Debowski T, Breneman D, Breneman J, Steele P: BCL-2 oncolprotein distinguishes benign from malignant in cutaneous lymphoid lesion biopsies. (poster). American and Canadian Academy of Pathology, San Francisco, CA, 3/13-14/94.
36. Tew JM, Breneman JC: Protocol for focal irradiation of skull base meningiomas. North American Skull Base Society, Orlando FL, 2/22/94.
37. Donaldson S, Asmar L, Fryer C, Wharam M, Breneman J, Gehan E, Maurer H: A hyperfractionated radiation protocol to improve local control without increasing late effects in childhood rhabdomyosarcoma. Int Soc of Ped Onc (SIPO) XXVth Meeting, Paris, 9/20-24/94.
38. Donaldson S, Asmar L, Breneman J, Fryer C, Gehan E, Glicksman A, Maurer H, Wharam M: Is hyperfractionated radiation plus chemotherapy feasible and tolerable in children with rhabdomyosarcoma? 36th Annual ASTRO Meeting, San Francisco, CA, 10/2-6/94.
39. Lamba MAS, Warnick RE, Breneman JC, Elson HR, Foster AE, Aron BS: A refixation device for fractionated stereotactic radiosurgery, 36th Annual ASTRO Meeting, San Francisco, CA 10/2- 6/94.
40. Raney RB, Asmar L, Newton WA, Newton W, Bagwell C, Breneman J, et al: Ewing's sarcoma of soft tissues (Extraosseous Ewing's) in childhood: A report of the Intergroup Rhabdomyosarcoma Study, 1972-1991. International Symposium on Childhood Non- Rhabdomyosarcoma Soft-Tissue Sarcomas, Padova, Italy, 2/11/94. Also presented at the 30th Annual Meeting of the American Society of Clinical Oncology, Dallas, TX, 5/17/94.
41. Kokkino A, Warnick RE, Breneman JC, Albright, Lamba M, Tew JM: Stereotactic radiosurgery for treatment of multiple (3 or more) brain metastases. Annual Mtg of the Congress of Neurological Surgeons, Chicago, IL, October 1994.
42. Breneman DL, Montsinger MA, VanHorn JA, Cohen RM, Breneman JC: Transient gynecomastia as an adverse effect of total skin electron beam irradiation for the treatment of cutaneous T-cell lymphoma. American Academy of Dermatology Annual Meeting, New Orleans, LA, 2/4-2/8/95.
43. Taha JM, Lamba MA, Samaratunga C, Breneman JC, Warnick RE: A method to reduce systematic spatial shift associated with magnetic resonance imaging for stereotactic surgery. Quadrennial Mtg of the American Society for Stereotactic and Functional Neurosurgery, Marian del Rey, CA, March 1995.
44. Warnick RE, Taha JM, Narayan S, Gaskill-Shipley M, Lamba M, Dhawan AP, Breneman JC, Albright RE: Early Detection of Postoperative Residual Tumor Using Image Fusion Subtraction. Mtg of the American Assoc. of Neurological Surgeons, Orlando, FL, April 1995.
45. Lobe TE, Wiener E, Andrassy R, Bagwell CE, Hays D, Crist B, Webber B, Breneman JC, Reed M, Tefft MC, Heyn R: The argument for conservative, delayed surgery in the management of rhabdomyosarcoma (RMS). Am. Acad. Ped. Sect. on Surg., San Francisco, October, 1995.
46. Breneman JB, Shehata N, Luo C, Lamba M, Taha J, Warnick R: Lack of Dose Response for Intracavitary P-32 Treatment of Intracranial Tumors (poster). 11th International Conference of Brain Tumor Research and Therapy, Napa, CA, 10/31-11/3/95.
47. Breneman D, VanHorn J, Breneman J: Cutaneous T-cell lymphoma: How much does it cost? (poster). American Academy of Dermatology Annual Meeting, Washington, DC, 2/10-2/14/96.
48. Warnick RE, Taha JM, Narayan S, Gaskill-Shipley M, Lamba M, Dhawan AP, Breneman JC, Albright RE: Early Detection of Postoperative Residual Tumor Using Image Fusion Subtraction: Preliminary Results. 11th International Conference of Brain Tumor Research and Therapy, Napa, CA, 10/31-11/3/95.
49. Breneman JC, Warnick RE, Albright RA, et al: Stereotactic Radiosurgery for the Treatment of Brain Metastases: Results of a Single Institution Series (poster). Congress of Neurological Surgeons Annual Meeting, Montreal, Quebec, Canada, September 28-October 3, 1996.
50. Wiener E., Grier H., Breneman JC, et al: Changing Pattern of Relapse with Localized Paratesticular Rhabdomyosarcoma in the Intergroup Rhabdomyosarcoma Study (IRS) Group Trials. ASCO, Denver, CO, May 1997.
51. Patel SM, Breneman J, Warnick R: Resection and Permanent I-125 Seed Placement in Patients with Recurrent Glioblastoma Multiforme. Ohio State Radiological Society Annual Meeting, Cleveland, OH, May 10, 1997.53.Breneman J: Use of Stereotactic Radiosurgery for the Treatment of Intracranial Disease. Indiana Society ofRadiation Oncology, Indianapolis, IN, Nov. 22, 1997.
52. Kager C, Warnick R, Breneman J: Repeat Stereotactic Radiosurgery.
53. Breneman DL, Storer TJ, Breneman J, Mutasim DF: Methotrexate-Induced Cutaneous Ulceration in Patients with Mycosis Fungoides. American Acadamy of Dermatology Annual Meeting, Orlando, FL, Feb 27 - Mar 3, 1998.
54. Breneman DL, Raju US, Breneman JC, Steele PE, Swerdlow SH, Cualing HD: LN Grading for Staging of Mycosis Fungoides May Benefit from Examination of Multiple Excised Lymph Nodes. American Acadamy of Dermatology Annual Meeting, Orlando, FL, Feb 27 - Mar 3, 1998.
55. Aron BS,, Freese D, Breneman JC, Lehmkuhl-Biehl A: WilmÕs tumor: A comparative look at the disease over two twenty-year periods (1950-1970), 1971-1995). 17th International Cancer Congress, Rio de Janeiro, Brazil, Aug 23-28, 1998.
56. Kager CD, Sherman JD, Ward J, Breneman JC. Stereotactic radiosurgery for brainstem and thalamic neoplasms. Society for Linac Radiosurgery Annual Meeting, Orlando, Florida. Dec. 1998.
57. Breneman DL, VanHorn JA, Breneman JC: Cutaneous T-cell lymphoma and patient support groups. American Academy of Dermatology annual meeting, New Orleans, Louisiana 3/14/99.
58. Kulow BF, Breneman DL, Cualing H, Steele P, Breneman JC, Van Horn J, Mutasim DF. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. American Academy of Dermatology annual meeting, New Orleans, Louisiana 3/14/99.
59. Malogolowkin MH, Sposto R, Grovas L, Breneman JC, Womer R, Ortega JA. Lack of improvement in survival of children with metastatic rhabdomyosarcoma (RMS) treated with intensive therapy followed by stem cell transplant (SCT) for control of minimal residual disease. ASCO 35th Annual Meeting, Atlanta, Georgia, May 15-18, 1999.
60. Gaynon PS, Harris RE, Stram DO, Atlman AJ, Bostrom BC, Breneman JC, et. al. Asparagine (ASN) depletion and treatment response in childhood acute lymphoblastic leukemia (ALL) after an early marrow relapse: A ChildrenÕs Cancer Group trial (CCG-1941). Am Soc Of Hematology 1999 Annual Meeting.
61. Tew JM, Breneman JC, et. al. Tumor control and reversal of cranial nerve deficits after focused radiation therapy for intracvernous meningiomas. American Academy of Neurosurgery annual meeting, Dec. 1999. Atlanta, Ga.
62. Albright RE, Breneman JC, Warnick RE, Tobler W, Tew JM, VanLoveren H. A phase I study of treatment for patients with relapsed malignant glioma using concurrent permanent I-125 interstitial seeds and dose escalation fo gliadel 3.85% BCNU polymer wafers. Society for Neuro-Oncology Annual meeting, Nov 18-21, 1999, Scottsdale Az. (poster)
63. Breneman JC, Warnick RE, Albright RE. Permanent I-125 implants and 3D conformal radiotherapy for the treatment of newly diagnosed glioblastoma multiforme. Society for Neuro-Oncology Annual meeting, Nov 18-21, 1999, Scottsdale Az. (poster)
64. Breneman JC, Warnick RE, Albright Re. Three dimensional dosimetry of permanent I-125 implants for recurrent brain tumors. Society for Neuro-Oncology Annual meeting, Nov 18-21, 1999, Scottsdale Az. (poster)
65. Sanghave SN, Miranpuri SS, Chappell R, Buatti MJ, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Meta MP. Potential survival advantage from radiosurgery for patients with brain metastases: A multi- institutional analysis stratified by the RTOG recursive partitioning analysis methodology. American Society of Therapeutic Radiology and Oncology annual meeting. Nov. 1999, San Antonio, Texas.
66. Kager CD, Ward J, Warnick RE, Crone KR, Breneman JC. Linear accelerator (LINAC) based stereotactic radiosurgery in the pediatric population. American Academy of Neurosurgery annual meeting. Dec. 2, 1999. Atlanta, Ga.
67. Kager CD, Ward J, Warnick RE, Crone KR, Breneman JC. Linear accelerator (LINAC) based stereotactic radiosurgery in the pediatric population. LINAC Radiosurgery Society Annual Meeting. Dec. 10, 1999. Lake Buena Vista, Fl.
68. McGill B, Lamba, M, Gaskill-Shipley M, Breneman JC. Use of a linear accelerator-based radiosurgery system for the treatment of trigeminal neuralgia: Technical considerations. LINAC Radiosurgery Society Annual Meeting. Dec. 10, 1999. Lake Buena Vista, Fl.
69. Breneman JC. New developments in image-based radiotherapy. Cedars-Sinai Medical Center Conference of the Management of Brain Tumors Using the Latest Technology. Feb. 2, 2000. Los Angeles, Ca.
70. Breneman JC, Warnick RE, Albright RE. Permanent I-125 implants and 3D conformal radiotherapy for the treatment of newly diagnosed glioblastoma multiforme. American Assoc Neurological Surgery Fourth Biennial Brain Tumor Symposium. April 13-14, 2000. San Francisco, Ca.
71. Aziz K, Froelich SC, Sanan A, VanLoveren H, Breneman JC, Tew JM. Reversal of cranial nerve deficits after radiosurgery for cavernous sinus meningiomas. 12th Annual Meeting of the North American Skull Base Society, March 3-6, 2001. Lake Buena Vista, Florida.
72. Augsburger JJ, Schneider S, Narayana A, Breneman JC, Aron BS, Barrett WL. Plaque radiotherapy of choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension. International Congress of Ocular Oncology, June 17-21, 2001, Amsterdam, The Netherlands.
73. Breneman JC, VanLoveren H. Acoustic Neuromas: Treatment Options. Acoustic Neuroma Association 15th National Symposium. June 22, 2001. Cincinnati, Ohio.
74. Breneman JC. Keynote Address: Contemporary Perspectives on Acoustic Neuroma Radiotherapy. Acoustic Neuroma Association 15th National Symposium. June 22, 2001. Cincinnati, Ohio.

LOCAL PRESENTATIONS:

1. The use of radiation therapy in the treatment of skin diseases. Dermatology Basic Science Lecture Series, 5/86.
2. Bone marrow transplantation. Greater Cincinnati Society of Radiation Therapy Technologists, 5/87.
3. Current concepts in mycosis fungoides. Dermatology Grand Rounds, 8/87.
4. Stereotactic radiosurgery. Cincinnati Neuro-Oncology Society, 4/91.
5. Radiotherapy. Cincinnati Nursing Oncology Board Review Course, 4/91.
6. Radiation in the treatment of breast cancer. Adams County Continuing Medical Education Program, 2/88.
7. Radiotherapy. Cincinnati Nursing Oncology Board Review Course, 3/88.
8. The physical and biological basis of radiotherapy. Dermatology Basic Science Lecture Series, 4/88.
9. Radiation brain necrosis. Neurology/Neurosurgery Grand Rounds, 6/88.
10. Radiotherapy. Cincinnati Nursing Oncology Board Review Course, 3/89.
11. Dermatologic radiation therapy. Dermatology Grand Rounds, 9/89.
12. Stereotactic radiosurgery. Dermatology Grand Rounds, 12/89.
13. Advances in mycosis fungoides. Dermatology Grand Rounds, 12/89.
14. Radiotherapy. Cincinnati Nursing Oncology Board Review Course, 2/90.
15. Treatment of craniopharyngiomas. Neurology/Neurosurgery Grand Rounds, 2/90.
16. Stereotactic radiosurgery. Miami Valley Hospital, Dayton, Ohio, 3/90.
17. Pituitary adenomas. Neurology/Neurosurgery Grand Rounds, 10/90.
18. Stereotactic radiosurgery. Cincinnati Neuro-Oncology Society, 4/91.
19. Principles of radiation. Cincinnati Oncology Nursing Board Review Course, 4/91.
20. Radiotherapy. Cincinnati Nursing Oncology Board Review Course, 4/91.
21. Radiotherapy for treatment of skin and breast cancer. Plastic Surgery Grand Rounds, 7/91.
22. Stereotactic radiosurgery. Radiology Grand Rounds, 9/91.
23. Radiosurgery update. Neurology/Neurosurgery Grand Rounds, 9/91.
24. Radiosurgery. Cincinnati Radiation Therapy Technology Society, 10/91.
25. Radiation Safety. Clinical Neuroscience Course, 10/91.
26. Radiotherapy in Dermatology. Dermatology Basic Science Lecture, 5/92.
27. Radiation and Radiosurgery for Meningiomas. The Mayfield-Airing Neuroscience Symposium, Cincinnati, OH, 5/93.
28. Radiosurgery and Brachytherapy as Focal Treatments for Gliomas. The Mayfield-Airing Neuroscience Symposium, Cincinnati, OH, 5/93.
29. Electron Beam Radiotherapy in Dermatology. American Academy of Dermatology Annual Meeting, Washington, D.C., 12/93.
30. Radiotherapy in Dermatologic Disease. Dermatology Grand Rounds, 8/26/93.
31. Stereotactic radiosurgery, The Christ Hospital Neurosurgery Grand Rounds, 4/25/94.
32. Specialized Radiation Techniques for Brain Tumors. Brain Tumor Research Meeting, 5/10/94.
33. Radiation Techniques for Brain Tumors. Clinical Neuroscience Lecture, 10/5/94.
34. New Technologies in Radiation Therapy. Hematology/Oncology Grand Rounds, 5/26/95.
35. Radiosurgical Applications to Skull Base Tumors. Contemporary Neurosurgical Techniques Course, 9/7/95.
36. 3-D Conformal Radiation Therapy. The Christ Hospital Tumor Board, 1/23/96.
37. Stereotactic Radiosurgery for the Treatment of Brain Metastases. The Christ Hospital Neurosurgery Grand Rounds, 6/28/96.
38. Stereotactic Radiosurgery for the Treatment of Brain Metastases. University of Cincinnati Neurosurgery Grand Rounds, 10/16/96.
39. Use of Radiation Therapy in Dermatology. University of Cincinnati Dermatology Grand Rounds, 7/29/99.
40. Neuro-Oncology Update. Neurosurgery Grand Rounds, 8/18/99.
41. Lexar Ð A Virtual Field Trip. 1999 Midwest Regional Brain Tumor Conference. Cincinnati, Ohio, Oct. 2, 1999.
42. High Precision Radiotherapy. 1999 Midwest Regional Brain Tumor Conference. Cincinnati, Ohio, Oct. 2, 1999.
43. Stereotactic Radiosurgery. Cincinnati Trigeminal Neuralgia Support Group. Cincinnati, Ohio, July 11, 2000.
44. Radiotherapy of Acoustic Neuromas. University of Cincinnati Neurosurgery Grand Rounds. Cincinnati, Ohio, March 14, 2001.

PUBLICATIONS:

1. McLaurin R, Breneman JC, Aron B: Hypothalamic gliomas: Review of eighteen cases. Concepts in Pediatric Neurosurgery 7:19-28, 1987.
2. Breneman JC, Bradshaw AE, Gluckman J, Aron BS: Prevention of stomal recurrence in patients requiring emergency tracheostomy for advanced laryngeal and pharyngeal tumors. Cancer 62:802-805, 1988.
3. Denman DL, Elson HR, Lewis GC Jr, Breneman JC, et al: The distribution of power and heat produced by interstitial microwave antenna arrays: I. Comparative phantom and canine studies. Int J Radiat Oncol Biol Phys 14(1):127-137, 1988.
4. Denman DL, Foster AE, Lewis GC Jr, Redmond KP, Elson HR, Breneman JC, et al: The distribution of power and heat produced by interstitial microwave antenna arrays: II. The role of antenna spacing and insertion depth. Int J Radiat Oncol Biol Phys 14(3):537-545, 1988.
5. Van Aken ML, Breneman JC, et al: Incorporation of patient immobilization, tissue compensation and matchline junction technique for three-field breast treatment. Medical Dosimetry 13:131-135, 1988.
6. Breneman JC, Elson HR, et al: A technique for delivery of total body irradiation for bone marrow transplantation in adults and adolescents. Int J Radiat Oncol Biol Phys 18:1233-1236, 1990.
7. Margolin SG, Breneman JC, et al: Management of radiation-induced moist skin desquamation using hydrocolloid dressing. Cancer Nursing 13(2):71-80, 1990.
8. Breneman JC, Mitchell SE, et al: Concurrent radiotherapy and chemotherapy for locally advanced non-small cell cancer of the lung: Report of a clinical trial and review of the literature. Am J Clin Oncol 14(1):9-15, 1991. Also abstracted in Current Opinion in Oncology, 1993, Current Science, Ltd., Philadelphia, PA, USA.
9. Breneman DL, Like A, Ballman EA, Pruermer JM, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in mycosis fungoides - Uniformity of distribution and potential for environmental contamination. J Amer Acad Dermatol 25:1059-1064, 1991. Also abstracted in Year Book of Dermatology, 1993, Mosby Year Book Inc., St. Louis, USA.
10. Breneman JC, Sawaya R: Cerebral radiation necrosis. Perspectives in Neurological Surgery 2(2):127-140, 1991.
11. Breneman JC: Irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 21:1393, 1991.(letter)
12. Foss FM, Ihde DC, Breneman DL, Phelps RM, Fischmann AB, Schechter GP, Linnoila I, Breneman JC, et al: Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2A in advanced mycosis fungoides/Sezary syndrome. J Clin Oncol 10:1907-1913, 1992.
13. Breneman DL, Breneman JC: Topical mechlorethamine in the treatment of mycosis fungoides. J Am Acad Dermatol 27(5):786-787, 1992 (letter).
14. Sawaya R, Breneman JC: Design of a cap for radioshielding during treatment with interstitial I-125 brain implants. J Neuro Oncol 16:233-234, 1993.
15. Cherlow J, Steinherz P, Sather H, Gaynon P, Grossman N, Kersey J, Maurer H, Breneman JC: The role of radiation therapy in the management of acute lymphoblastic leukemia with lymphomatous presentation. Int J Radiat Oncol Biol Phys 27:1001-1009, 1993.
16. Breneman JC: Stereotactic radiosurgery. The Cancer Bulletin 45:346-350, 1993.
17. Breneman DL, Breneman JC: Cutaneous T-cell lymphoma mimicking porokeratosis of Mibelli. J Amer Acad Dermatol 29:1046-1048, 1993.
18. Warnick RE, Breneman JC: Stereotactic radiosurgery for metastatic brain tumors. MNI Findings 2:1-2, 1993.
19. Goldschmidt H, Breneman JC, Breneman DL: Ionizing radiation therapy in dermatology. J Am Acad Dermatol 30:157-182, 1994.
20. Tomsick TA, Ernst RJ, Tew JM, Brott TG, Breneman JC: Adult choroidal vein of Galen malformation: Case report. Am J Neuro Radiol, 16:861-865, Apr 1995.
21. Donaldson S, Asmar L, Breneman JC, Fryer C, et al: Hyperfractionated radiation in children with rhabdomyosarcoma - Results of an Intergroup Rhabdomyosarcoma Pilot Study. Int J Rad Onc Biol Phys, 32:903-911, 1995.
22. Breneman J and Breneman D: Response to Total Skin Irradiation for Mycosis Fungoides Associated with Lymphomatoid Papulosis: Regarding Wilson, et al. Int J Rad Onc Biol Phys, 32:274, 1995. (letter)
23. Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, et al: Cytoreduction and prognosis in acute lymphoblastic leukemia - The importance of early marrow response: Report from the Childrens Cancer Group. J Clin Oncol 14:389-398, 1996.
24. Lobe T, Wiener E, Andrassy R, Bagwell C, Hays D, Crist W, Webber B, Breneman J, Reed M, Tefft M, and Heyn R: The Argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma (RMS) J Ped Surg 31:1084-1087, 1996.
25. Raney RB, Asmar L, Newton WA, Bagwell C, Breneman J, et al: Ewing's sarcoma of soft tissues in childhood: A report of the Intergroup Rhabdomyosarcoma Study, 1972-1991. J Clin Oncol 15:574-582, 1997.
26. Taha JM, Lamba MA, Samaratunga C, Breneman JC, Warnick RE: A method to reduce systematic spatial shift associated with magnetic resonance imaging. J Stereo Funct Neurosurg 66:118-122, 1996.
27. Breneman JC, Warnick RE, Albright RE, Kukiatinant N, Shaw J, Armin D, and Tew J: Stereotactic radiosurgery for the treatment of brain metastases: Results of a single institution series. Cancer 79:551-7, 1997.
28. Breneman JC: Genitourinary Rhabdomyosarcoma. Sem Rad Oncol 7:217-224, 1997.
29. Arndt C, Tefft M,Gehan E, Anderson J, Jenson M, Link M, Donaldson S, Breneman J, Wiener E, Webber, Maurer H: A feasibility, toxicity, and efficacy study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS) IV Pilot Study. J Ped Hem Onc 19:124-129, 1997.
30. Wharam MD, Hanfelt JJ, Tefft MC, Johnston J, Ensign LG, Breneman J, et al: Radiation Therapy for Rhabdomyosarcoma: Local Failure Risk for Clinical Group III Patients on IRS-II. Int J Rad Oncol Biol Phys 38:797-804, 1997.
31. Breneman DL, Breneman JC: Evaluation and treatment of patients with cutaneous T-cell lymphoma. J Ger Derm 5:339-346, 1997.
32. Breneman JC, Breneman DL: Use of radiotherapy in the treatment of mycosis fungoides. J Ger Derm 5:358-363, 1997.
33. Fodor J, Breneman J, Lamba M, Foster A, Elson H: Modification of a Linear Accelerator Table Top for Non-Coplanar Conformal Brain Radiotherapy. Medical Dosimetry 23:27-29, 1998.
34. Raney RB, Asmar L, Newton WA, Bagwell C, Breneman J, et al: Ewing's sarcoma of soft tissues in childhood: A report of the Intergroup Rhabdomyosarcoma Study, 1972-1991. J Clin Oncol 15:574-582, 1997.
35. Steinherz PG, Gaynon PS, Breneman JC, et al. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognositc features: Randomized controlled trial from the ChildrenÕs Cancer Group. Cancer 82:600-612, 1998.
36. Beech TR, Moss RL, Anderson JA, Maurer HM, Qualman SJ, Breneman JC, Wiener JC, Crist WM. What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? A report from the Intergroup Rhabdomyosarcoma Study Group. J Ped Surg 34:668-671, 1999.
37. Wolden SL, Anderson JR, Crist WM, Breneman JC, et. al. Indication for radiotherapy in addition to chemotherapy for completely resected rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I-III. J Clin Oncol 17:3468-3475, 1999.
38. Patel S, Breneman JC, Albright R, Warnick RE. Permanent interstitial I-125 implantation for recurrent glioblastoma multiforme. Neurosurgery, 46:1123-8 (discussion 1128-30), 2000.
39. Sherman JD, Kager CD, Ward J, Warnick RE, Breneman JC. Stereotactic radiosurgery for brainstem and thalamic neoplasms. J Radiosurg, 3:133-138, 2000.
40. Breneman JC, Wiener ES: Issues in the local control of rhabdomyosarcoma. Med and Ped Oncol. 35:104-109, 2000.
41. Baker KS, Anderson JR, Link MP, Grier HE, Qualman SJ, Maurer HM, Breneman JC, Wiener ES, Crist WM: Benefit of Intensified Therapy for Patients with Local or Regional Embryonal Rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 18:2427-2434, 2000.
42. Moyer PD, Golnik KC, Breneman J: Treatment of optic nerve sheath meningioma with three-dimensional conformal radiation. Am J Ophthalmol 129:694-696, 2000.
43. Bott-Kothari T, Breneman JC, Warnick RE. Metastatic hepatoma to the brain treated with stereotactic radiosurgery. J Stereotactic Radiosurg, 3:139-144, 2000.
44. Sanghave SN, Miranpuri SS, Chappell R, Buatti MJ, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Meta MP. Potential survival advantage from radiosurgery for patients with brain metastases: A multi-institutional analysis stratified by the RTOG recursive partitioning analysis methodology Int J Radiat Oncol Biol Phys 51;426-434, 2001.
45. Crist WM, Anderson JR, Fryer C, Raney RB, Ruymann FB, Breneman J, et al: The Intergroup Rhabdomyosarcoma Study-IV: Results for patients with non-metastatic disease. J Clin Oncol 19:3091-3102, 2001.
46. Pappo AS, Lyden E, Breneman J, et al: "Up-front" window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: An Intergroup Rhadomyosarcoma Study (IRSG). J Clin Oncol 19:213-219, 2001.
47. Spunt SL, Anderson JR, Teot LA, Breneman JC, Meyer WH, Pappo AS. Routine brain imaging is unwarranted in asymptomatic patients with non-head-and-neck rhabdomyosarcoma metastatic at diagnosis: A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG). Cancer 92(1):121-125, 2001.
48. Smith LM, Anderson JR, Qualman SJ, Crist WM, Paidas CH, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Maurer HM, Donaldson SS. Which patients with rhabdomyosarcoma (RMS) and microscopic residual tumor (group II) fail therapy? A report from the Soft Tissue Sarcoma Committee of the ChildrenÕs Oncology Group. J Clin Oncol 19:4058-4064, 2001.
49. Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, Wharam M. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma Ð A report from the IRSG. Int J Radiat Oncol Biol Phys 51:718-728, 2001.
50. Barrett WL, Aron BS, Breneman JC, Narayana A, Redmond KP. Clinical oncology clerkship for third-year medical students. J Cancer Educ 16:182-184, 2001.
51. Glod J, Koch B, Myseros J, Breneman JC, Collins MH. Issues concerning the treatment of a child with a craniopharyngioma. Med Ped Oncol 38:360-367, 2002.
52. Raney RB, Meza J, Anderson JR, Fryer CJ, Donaldson SS, Breneman JC, et al. Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Group protocols IRS-II through IV, 1978-1997. Med Ped Oncol 38:22-32, 2002.
53. Kulow BF, Cualing H, Steele P, Breneman JC, Van Horn J, Mutasim DF, Breneman DL: The progression of cutaneous B-cell pseudolymphoma (CBPL) to cutaneous B-cell lymphoma (CBCL). In Press, J Cutan Med Surg.
54. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP. A multi-instutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. In press, Int J Rad Oncol Biol Phys.
55. Breneman JC, Lyden E, Baker S, et. al. Prognostic factors and clinical outcome in children and adolescents with metastatic rhabdomyosarcoma Ð A report from the Intergroup Rhabdomyosarcoma Study. In press, J Clinc Oncol.
56. Breneman DL, Storer T, Breneman JC, Mutasim DF: Methotrexate-induced cutaneous ulceration in patients with mycosis fungoides. Submitted to J Am Acad Derm.
57. Breneman DL, Raju US, Breneman JC, Steele PE, Swerdlow SH, Cualing HD: LN grading for staging of mycosis fungoides may benefit from examination of multiple excised lymph nodes. In press, J Am Acad Derm.
58. Jarrar M, Gaynon PS, Periclou AP, Fu C, Harris RE, Stram D, Altman A, Bostrom B, Breneman JC, Steele D, Trigg M, Zipf T, Avramis VI: Asparagine depletion after pegylated E. Coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first Bone Marrow Relapse: A ChildrenÔs Cancer Group study (CCG-1941). In press, Blood.
59. Kager CD, Ward J, Warnick RE, Breneman JC. Repeat stereotactic radiosurgery for the treatment of recurrent or newly developed brain metastases. Submitted to J Stereotactic Radiosurg.
60. Augsburger JJ, Schneider S, Narayana A, Breneman JC, Aron BS, Barrett WL. Plaque radiotherapy of choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension. (in manuscript)
61. Joshi D, Anderson J, Paidas C, Breneman JC, Parham D, Hawkins D, Baker S, Walterhouse D, Crist W. Age is an independent prognostic factor in rhabdomyosarcoma: A report from The Soft Tissue Sarcoma Committee of the ChildrenÕs Oncology Group. (in manuscript).
62. Breneman JC, Balasa V, Arceci W. Evidence of tumor-protective effect from amifostine during radiotherapy for Hodgkins disease: A case report. (in manuscript)
63. Cohen P, Link MJ, Breneman JC, Tew JM. Malignant squamous degeneration of a cerebellopontine angle epidermoid tumor. Management and excellent response to radiotherapy. (In manuscript).

BOOK CHAPTERS:

1. Breneman JC: Electron Beam Therapy. In Modern Dermatologic Radiation Therapy, Goldschmidt H/Panizzon RG (eds), Springer- Verlag, New York-Heidelberg, 1990.
2. Myer C, Mortelliti A, Yanik G, Klopfenstein K, Breneman J: Malignant and Benign Tumors of the Head and Neck in Children. In Pediatric Facial Plastic and Reconstructive Surgery, Smith and Bumsted (ed). Raven Press, New York, NY, 1992.
3. Breneman JC, Donaldson S, Hays D: The Management of Pediatric Genitourinary Rhabdomyosarcoma. In The Comprehensive Textbook of Genitourinary Oncology, Volgelzang, Scardino, Shipley, and Coffey (eds). William & Wilkins, Baltimore, MD, 1995.
4. Breneman JC: Radiation Therapy. In Hematology/Oncology/BMT Handbook, 1st edition, Childrens Hospital Medical Center, Cincinnati, OH, 1995.
5. Breneman DL, VanHorn JA, Breneman JC: Costs of Evaluating and Treating Patients with Cutaneous T-Cell Lymphoma. In Care Management of Skin Diseases, Rajagopalan, Sherertz, and Anderson (eds). Marcel Dekker, Inc., New York, NY, 1997.
6. Donaldson SS and Breneman JC: Rhabdomyosarcoma. In Principles and Practice of Radiation Oncology, 3rd edition, Perez and Brady (eds). J.B. Lippincott Co., Philadelphia, PA, 1998.
7. Breneman JC, Donaldson S, Wiener ES, Baker S: The Management of Pediatric Genitourinary Rhabdomyosarcoma. In The Comprehensive Textbook of Genitourinary Oncology, 2nd edition, Volgelzang, Scardino, Shipley, and Coffey (eds). William & Wilkins, Baltimore, MD, 2000.
8. Breneman JC, Narayana A: Principles of Pediatric Radiotherapy. In Cancer Medicine, 5th edition, Holland, Frei, Bast, Kufe, Pollock, Weichselbaum (eds). B.C. Decker, Hamilton, Ont. In Press.
9. Breneman JC, Donaldson SS: Rhabdomyosarcoma. In Principles and Practice of Radiation Oncology, 4th edition, Perez and Brady (eds). J.B. Lippincott Co., Philadelphia, PA, in press.

ABSTRACTS:

1. Denman DL, Foster AE, Lewis GC, Redmond KP, Clausen CL, Elson HR, Breneman JC, Aron BS: The role of implant spacing and insertion depth on the distribution of heat from interstitial microwave antennas. Veterinary Cancer Society Meeting, 4/28-30/86.
2. Van Aken ML, Breneman JC, et al: Incorporation of patient immobilization, tissue compensation and matchline junction technique for three-field breast treatment. Presented at the 13th Annual Meeting of the American Association of Medical Dosimetrists, 6/26-7/1/88.
3. Breneman JC, Elson HR, et al: A technique for delivery of total body irradiation for bone marrow transplantation in adults and adolescents. Presented at the American Society for Therapeutic Radiology and Oncology Annual Meeting, 10/10-14/88.
4. Foss F, Fischmann A, Schechter G, Ihde, D, Breneman D, Breneman J, et al: Phase II trial of pentostatin and interferon-alpha-2A in advanced mycosis fungoides/Sezary syndrome. Proc ASCO 8:276, 1989.
5. Heerema N, Arthur D, Steinherz P, Gaynon P, Sather H, Breneman JC, et al: Children with acute lymphoblastic leukemia with lymphomatous features (ALL-LF) and normal marrow chromosomes have a better outcome than patients with abnormal chromosomes. Proc Am Soc Clin Oncol 9:219, 1990.
6. Foss F, Fischmann A, Schechter G, Ihde D, Breneman D, Breneman JC, Sausville E: Phase II trial of human interferon-alfa-2A and pentostatin in advanced stage mycosis fungoides/Sezary syndrome. Proc Am Soc Clin Oncol 9:259, 1990.
7. Steele P, Breneman DL, Breneman JC, et al: Genotypic analysis of lymph nodes in cutaneous T cell lymphomas: Comparison with histologic "LN" grading. United States and Canadian Academy of Pathology Annual Meeting, 3/90.
8. Cherlow J, Steinherz P, Sather H, Gaynon P, Grossman N, Kersey J, Maurer H, Breneman JC, et al: The role of radiation therapy in the management of acute lymphoblastic leukemia with lymphomatous presentation (ALL/LP). Int J Radiat Oncol Biol Phys 19(S1):176, 1990.
9. Steinherz P, Gaynon P, Breneman JC, et al: Treatment of acute lymphoblastic leukemia with lymphomatous presenting features. Med Ped Oncol 19:412, 1991.
10. Steinherz P, Gaynon P, Breneman J, et al: Acute lymphoblastic leukemia (ALL) with lymphomatous features at diagnosis in children. Proc ASCO Annual Meeting, San Diego, California, 5/92.
11. Sorensen SM, Barron DR, Breneman DL, Breneman JC, Swerdlow SH: Paraffin section immunohistologic evaluation of cutaneous T-cell lymphomas (CTCL): The role of OPD4. Lab Invest 66:88A, 1992.
12. Breneman DL, Like-Nartker A, Ballman EA, Pruemer Jm, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in the treatment of mycosis fungoides - Uniformity of application and potential for environmental contamination. Proc of 18th World Congress of Dermatology, New York, NY, 6/92.
13. Breneman DL, Breneman JC, et al: Hair and nail changes following total skin irradiation. Proc of 18th World Congress of Dermatology, New York, NY, 6/92.
14. Breneman DL, Breneman JC, et al: Sezary syndrome: Long-term remission following topical corticosteroid therapy. Proc of 18th World Congress of Dermatology, New York, NY, 6/92.
15. Breneman DL, Swerdlow SH, Jacobs BS, Cline DJ, Barron DR, Ballman EA, Steele P, Breneman JC: Concurrent lymphomatoid papulosis and mycosis fungoides. Proc of 18th World Congress of Dermatology, New York, NY, 6/92.
16. Breneman DL, Swerdlow SH, Breneman JC, et al: Concurrent Ki-1 lymphoma, lymphomatoid papulosis, and mycosis fungoides. Proc of 18th World Congress of Dermatology, New York, NY, 6/92.
17. Malik S, Mazewski C, Lucky A, Breneman JC, et al: Ultraviolet-B and total skin electron beam therapy for refractory cutaneous lesions of Langerhans cell histiocytosis: A case report. Am Soc of Ped Hem Oncol, Chicago, IL, 9/24-26/92.
18. Breneman JC, Lamba M, Foster A, Elson H, Aron B: Treatment planning of stereotactic brain implants using an interactive graphical system. Proc of 34th Annual ASTRO Meeting, 1992, pp. 291-292.
19. Breneman JC, Lamba M, Foster AE, Elson HR, Aron BS: Treatment planning of stereotactic brain implants with an interactive graphic system. Radiology 185(P), Proc of 78th Scientific Assembly and Annual Meeting of the RSNA, Chicago, IL, 12/1/92, pp. 273.
20. Breneman DL, Like-Nartker A, Ballman EA, Pruemer JM, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in the treament of mycosis fungoides - uniformity of application and potential for environmental contamination. In The 1993 Year Book of Dermatology, AJ Sober, TB Fitzpatrick, eds. Mosby-Year Book, Inc., St. Louis, 1993, pp. 365-366.
21. Steinherz P, Gaynon P, Breneman JC, Cherlow J, Grossman N, Johnstone H, Kersey J, Sather H, Trigg M, Bleyer A: Early marrow response is a powerful predictor of outcome in acute lymphoblastic leukemia patients with unfavorable presenting features. Proc Am Assoc Cancer Res, 1994; 35:240.
22. Warnick RE, Breneman JC, Albright R, Tew J, Lamba M, Aron BS: Stereotactic Radiosurgery for treatment of multiple (3 or more) brain metastasis. Proc ASCO, 1994; 13:177.
23. Childress L, Litz G, Cualing H, Debowski T, Breneman D, Breneman J, Steele P: BCL-2 oncolprotein distinguishes benign from malignant in cutaneous lymphoid lesion biopsies. American and Canadian Academy of Pathology, San Francisco, CA, 3/13-14/94.
24. Lamba MAS, Warnick RE, Breneman JC, Elson HR, Foster AE, Aron BS: A refixation device for fractionated stereotactic radiosurgery. Rad Onc Biol Phys, 30(S1):264.
25. Donaldson S, Asmar L, Breneman J, Fryer C, Gehan E, Glicksman A, Maurer H, Wharam M: Is hyperfractionated radiation plus chemotherapy feasible and tolerable in children with rhabdomyosarcoma? Pro 36th annual ASTRO, San Francisco, CA, 1994, p. 213.
26. Donaldson S, Asmar L, Fryer C, Wharam M, Breneman J, Gehan E, Maurer H, for the Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group, USA: A hyperfractionated radiation protocol to improve local control without increasing late effects in childhood rhabdomyosarcoma. SIOP XXVI meeting, p. 188.
27. Breneman J, Shehata N, Warnick R, Lamba M, Taha J: Dosimetry for P-32 Injections into Cystic Intracranial Tumors. Congress of Neurological Surgeons, October 1995.
28. Lobe TE, Wiener E, Andrassy R, Bagwell CE, Hays D, Crist WM, Webber B, Breneman JC, Reed M, Tefft MC and Heyn R: The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma (RMS). Proceeding of American Academy of Pediatrics, 1996.
29. Wharam M, Hanfelt J, Tefft M, Johnston J, Ensign L, Breneman J, et al: Radiation therapy for rhabdomyosarcoma: Local failure risk for clinical group III patients on IRS-II. Med Ped Oncol 27:235, 1996.
30. Childress L, Utz G, Cualing T, Debowsky T, Breneman D, Breneman JC, et al: BCC-2 Oncoprotein distinguishes benign from malignant in cutaneous lymphoid lesion biopsies.
31. Weiner E, Grier H, Breneman J, Lobe T, Andrassy R, Bagwell C, Maurer h, Anderson J, Changing pattern of relapse with localized paratesticular rhabdomyosarcoma in the Intergroup Rhabdomyosarcoma Study (IRS) Group trials. Proc Am Soc Clin Oncol. 16:519a, 1997.
32. Wiener ES, Andrassy R, Lobe TE, Bagwell CE, Breneman JC, et. al. Ages 10 to 14 have the highest risk of failure in group I-II paratesticular rhabdomyosarcoma (PTRMS) in IRS IV. Med Ped Oncol 31:385, 1998.
33. Malogolowkin MH, Sposto R, Grovas L, Breneman J, Womer R, Ortega JA. Lack of improvement in survival of children with metastatic rhabdomyosarcoma (RMS) treated with intensive therapy followed by stem cell transplant (SCT) for control of minimal residual disease. Proc Am Soc Clin Oncol 18:55a, 1999.
34. Martens J, Breneman JC, VanLoveren H, Taha J, Tew JM. Efficacy and morbidity of linac-based stereotactic radiosurgery (STRS) for the treatment of trigeminal neuralgia.
35. Dagnew E, Warnick RE, Breneman JC, VanLoveren H, Tew JM. Resection and permanent I-125 brachytherapy without whole brain radiotherapy for newly diagnosed single brain metastases.
36. Aziz K, Froelich SC, Sanan A, VanLoveren H, Breneman JC, Tew JM. Reversal of cranial nerve deficits after radiosurgery for cavernous sinus meningiomas. Skull Base: An interdisciplinary approach, volume 11 (suppl 1) March 2001.